1. Home
  2. Live Updates
  3. Jorgee cortes

Live Breaking News & Updates on Jorgee cortes

Stay informed with the latest breaking news from Jorgee cortes on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Jorgee cortes and stay connected to the pulse of your community

Rigel Pharma (RIGL) Announces Publication of Data on REZLIDHIA

Rigel Pharma (RIGL) Announces Publication of Data on REZLIDHIA
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states , Georgia , American , Raul-rodriguez , Jorgee-cortes , Cecilf-whitaker-jr , Georgia-cancer-center , Nasdaq , Rigel-pharmaceuticals-inc , American-cancer-society , Rigel-pharmaceuticals , Scholar-chair

Rigel Announces Publication of Data on REZLIDHIA® (Olutasidenib) in Post-Venetoclax Patients with Mutant IDH1 AML in Leukemia & Lymphoma

/PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced a peer-reviewed publication in Leukemia & Lymphoma on data from an analysis of the...

United-states , South-san-francisco , California , Georgia , American , David-rosen , Jorgee-cortes , Raul-rodriguez , Cecilf-whitaker-jr , Rigel-pharmaceuticals-inc , American-cancer-society , European-medicines-agency

Rigel Announces Poster Presentations at the 65th American Society of Hematology Annual Meeting and Exposition

/PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced the upcoming presentation of four posters highlighting data from their commercial...

California , United-states , Japan , Georgia , San-diego-convention-center , Texas , Houston , South-san-francisco , San-diego , Japanese , American , Jorgee-cortes

Cancer Researchers and Student Athletes Are "Here to Win" for Innovation, Discovery, and Hope

Building an innovative cancer research project takes time, creativity, and most importantly, a team of scientists working together on why a new way to treat cancer or keep the cancer from spreading to other parts of the body.

Georgia , United-states , Wier-stewart , Christenberry-fieldhouse , Jorgee-cortes , Francis-marion , Ryan-erlacher , Georgia-cancer-center , Cancer-center , Georgia-cancer-center-at-augusta-university , Augusta-university , Augusta-university-athletics

Rigel Announces Presentation of Data from Analysis of REZLIDHIA® (Olutasidenib) in Post-Venetoclax Patients with Mutant IDH1 AML

/PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced promising data from an analysis of the Phase 2 study evaluating REZLIDHIA®...

United-states , California , Georgia , South-san-francisco , American , Jorgee-cortes , Cecilf-whitaker-jr , David-rosen , Raul-rodriguez , Exchange-commission , Drug-administration , American-cancer-society

Dr. Cortes on Defining Fitness in Patients With Hematologic Malignancies

Jorge E. Cortes, MD, discusses the importance of defining fitness in patients with hematologic malignancies prior to treatment selection.

Georgia , United-states , Jorgee-cortes , Augusta-university , Georgia-cancer-center , Hematologic-oncology , Onclive-tv ,

Rigel Announces Publication of REZLIDHIA™ (olutasidenib) Phase 2 Clinical Results in Blood Advances

/PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced a peer-reviewed publication of data in Blood Advances, which summarizes clinical...

United-states , California , Georgia , South-san-francisco , American , Cecilf-whitaker-jr , David-rosen , Raul-rodriguez , Jorgee-cortes , Rigel-pharmaceuticals-inc , Drug-administration , Nasdaq

Rigel Pharma (RIGL) Announces Publication of REZLIDHIA Phase 2 Clinical Results

Rigel Pharma (RIGL) Announces Publication of REZLIDHIA Phase 2 Clinical Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Georgia , United-states , Cecilf-whitaker-jr , Raul-rodriguez , Jorgee-cortes , Rigel-pharmaceuticals-inc , Georgia-cancer-center , Drug-administration , Nasdaq , Wall-street , Blood-advances , Scholar-chair

Rezlidhia Approved for Relapsed/Refractory AML With IDH1 Mutation

The FDA has approved Rezlidhia (olutasidenib) for acute myeloid leukemia with a susceptible isocitrate dehydrogenase-1 (IDH1) mutation.

Georgia , United-states , Cecilf-whitaker-jr , Jorgee-cortes , Georgia-cancer-center , Drug-administration , Boxed-warning , Scholar-chair , Abbott-realtime ,

Rigel Pharma (RIGL) Announces U.S. FDA Approval of REZLIDHIA for Treatment of Adult Patients with R/R Acute Myeloid Leukemia with Susceptible IDH1 Mutation

Rigel Pharma (RIGL) Announces U.S. FDA Approval of REZLIDHIA for Treatment of Adult Patients with R/R Acute Myeloid Leukemia with Susceptible IDH1 Mutation
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Georgia , United-states , Cecilf-whitaker-jr , Raul-rodriguez , Jorgee-cortes , Rigel-pharmaceuticals-inc , Georgia-cancer-center , Forma-therapeutics-inc , Drug-administration , Nasdaq , Scholar-chair , Forma-therapeutics